VEGFC and type 2 diabetes mellitus: Disruption of lymphatic vessel integrity8,9 and attenuation of VEGF-C induced lymphangiogenesis10 have been reported as pathophysiological phenotypes in mice models of obesity and type 2 diabetes (T2D).